Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 454782Generated: October 30, 2026

Citric Acid → HCID 58508797, compound

https://huagongshe.com/reaction/454782

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCitric AcidHCID 311—
ReactantMorpholineHCID 8083—
ReactantCesium carbonateHCID 10796—
Reactant2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
ReactantTert-butyl 4-bromo-2-(5-phenylpyridine-3-carboxamido)benzoateHCID 58508430—
Catalystpalladium(II) acetateHCID 167845—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
SolventTolueneHCID 1140—
SolventEthyl AcetateHCID 8857—
ProductHCID 58508797HCID 58508797—

Reaction Steps

Cesium carbonate (0.14 g), morpholine (0.029 mL), 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (5 mg), tris(dibenzylideneacetone)dipalladium(0) (2 mg), and palladium(II) acetate (1 mg) were added to a toluene (3.0 mL) solution of tert-butyl 4-bromo-2-(5-phenylpyridine-3-carboxamido)benzoate (0.10 g), followed by heating to reflux under a nitrogen atmosphere for 1 hour. The reaction mixture was cooled to room temperature, and then morpholine (0.029 mL) was added thereto, followed by heating to reflux under a nitrogen atmosphere for 2 hours. The reaction mixture was cooled to room temperature, and then cesium carbonate (72 mg), morpholine (0.029 mL), 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (5 mg), tris(dibenzylideneacetone)dipalladium(0) (2 mg), and palladium(II) acetate (1 mg) were added thereto, followed by heating to reflux under a nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, and then ethyl acetate and a 10% aqueous solution of citric acid were added thereto. The organic layer was separated, washed with a saturated aqueous solution of sodium chloride, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography [eluent: 85-70% hexane/ethyl acetate] to obtain tert-butyl 4-morpholino-2-(5-phenylpyridine-3-carboxamido)benzoate.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08492582B2
Source datasetuspto-grants-2013_07
ORD IDord-768bb755152d4066bf6f584054a18db0
Source noteuspto-grants-2013_07